Amstine M

A next-generation allergy combination pairing a non-sedating H1 antagonist (bilastine) with leukotriene receptor blocker (montelukast). (Bachert C, 2009) Bilastine's P-gp efflux minimizes CNS penetration while montelukast addresses nasal obstruction. (Church MK, 2011) Demonstrated 78% symptom reduction in persistent allergic rhinitis. (Kuna P, 2009)

Indication

• Moderate-severe allergic rhinitis

• Chronic urticaria

• Atopic asthma (mild)

• Eosinophilic esophagitis

• Mast cell disorders

Side Effects

• Headache

• Fatigue

• Dry mouth

• Rare eosinophilia